论文信息 - First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer - 字舞流文

First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer

Yuankai Shi | X. Hao | P. Hu | Xin Zheng | Sheng Yang | Xingsheng Hu | Lin Wang | L. Ding | X. Cui | L. Mao | Sheng Yang